Therapy-related myelodysplastic syndrome and acute myeloid leukemia after autologous bone marrow transplantation: Dosis facit venenum? [3]

Journal of Clinical Oncology

Volumn 23, Issue 31, 2005, Pages 8120-8121

  Sill, Heinz ^a   Olipitz, Werner ^a   Schimek, Michael G ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ALKYLATING AGENT; CYCLOPHOSPHAMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CYTOGENETICS; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC RISK; HODGKIN DISEASE; HUMAN; LETTER; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; RADIATION DOSE; STEM CELL; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; MYELOID LEUKEMIA; NOTE; SECOND CANCER; WHOLE BODY RADIATION;

ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW TRANSPLANTATION; CYCLOPHOSPHAMIDE; HUMANS; LEUKEMIA, MYELOID; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; TRANSPLANTATION, AUTOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 32944467734     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.0643     Document Type: Letter

References (12)

1. Brown JR, Yeckes H, Friedberg JW, et al: Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 23:2208-2214, 2005
2. Lenz G, Dreyling M, Schiegnitz E, et al: Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem cell transplantation in patients with indolent lymphoma: Results of a prospective randomized trial of the German low grade lymphoma study group. J Clin Oncol 22:4926-4933, 2004
3. Josting A, Wiedenmann S, Franklin J, et al: Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's lymphoma study group. J Clin Oncol 21:3440-3446, 2003
4. Andre M, Mounier N, Leleu X, et al: Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVP regimen: A GELA cohort study on 2837 patients. Blood 103:1222-1228, 2004
5. Valagussa P, Santora A, Fossati-Bellani F, et al: Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4:830-837, 1986
6. van Leeuwen FE, Chorus AMJ, van den Belt-Dusebout AW, et al: Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 12:1063-1073, 1994
7. Abruzzese E, Radford JE, Miller JS, et al: Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation. Blood 94:1814-1819, 1999
8. Lillington DM, Micallef IN, Carpenter E, et al: Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma. J Clin Oncol 19:2472-2481, 2001
9. Allan JM, Wild CP, Rollinson S, et al: Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci U S A 98:11592-11597, 2001
10. [Erratum: Proc Natl Acad Sci U S A 98:15394, 2001]
11. Naoe T, Takeyama K, Yokozawa T, et al: Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 6:4091-4095, 2000
12. Olipitz W, Hopfinger G, Aguiar RCT, et al: Defective DNA-mismatch repair: A potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia. Genes Chromosomes Cancer 34:243-248, 2002